123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial
| Autor: | D.A. Colevas, K. Misiukiewicz, A.T. Pearson, J. Fayette, J.R. Bauman, D. Cupissol, E. Saada-Bouzid, D.R. Adkins, D.B. Marie, S.L. Cornen, P. André, F. Carrette, F. Rotolo, A. Boyer Chammard, R.B. Cohen |
|---|---|
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 32:S1432 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2021.10.142 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|